CIP
EXAS

Convergence Investment Partners’s Exact Sciences EXAS Stock Holding History

Convergence Investment Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,686
Closed -$252K – 167
2023
Q2 		$252K Buy
+2,686
New +$210K 0.14% 136

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Convergence Investment Partners's EXAS Position: Q3 2023 in Review

Convergence Investment Partners sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,686 shares — an estimated $252K sold.

Convergence Investment Partners first reported a position in EXAS in Q2 2023 and held it in 1 quarter. The position peaked at $252K in Q2 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Convergence Investment Partners reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Convergence Investment Partners sold 2,686 Exact Sciences shares in Q3 2023, an estimated $252K.
  • Convergence Investment Partners first reported a position in Exact Sciences in Q2 2023 and held it in 1 quarter.
  • Convergence Investment Partners's Exact Sciences position peaked at $252K in Q2 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Convergence Investment Partners's 13F filing for Q3 2023, filed 2 Nov 2023.